Health ❯Healthcare ❯Pharmaceuticals

Drug Pricing

Medicare Weight Loss Drugs Medicare Negotiations Prescription Drugs Market Competition Weight Loss Medications Eli Lilly Ozempic Medicare Negotiation Market Regulation

UK Mounjaro Orders Frozen Ahead of Price Hike as Korea Confronts Soaring Wegovy Use

Health bodies urge patients to seek supervised prescribing rather than bulk buying or turning to unlicensed sources.

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

Big Pharma Ramps Up Direct-to-Consumer Sales in Pricing Talks with Trump

Trump Gives Pharma Until September 29 to Match Lowest Global Drug Prices

HHS Opens Applications for 340B Rebate Model Pilot

Eli Lilly Seals Germany’s First Secret Rebate Deal for Mounjaro

Bristol Myers Squibb and Pfizer to Offer Eliquis at 40% Cash-Price Discount

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Merck Cuts 2025 Revenue Forecast, Pushes Ahead with US Expansion

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Trump’s Executive Order Targets U.S. Drug Prices with Foreign Rate Parity

Trump Signs Decree to Slash U.S. Drug Prices by Up to 80%

Trump Signs Sweeping Order to Cap U.S. Drug Prices at Global Lows

Trump Signs Executive Order to Slash U.S. Drug Prices by Up to 80%

Indian Pharma Stocks Decline as Trump Announces Major Drug Price Cuts

Trump to Revive Medicare Drug Pricing Plan via Executive Order

Trump Administration NIH Cuts Terminate $1.81 Billion in Research Funding